Vitamin D supplementation attenuates acute inflammatory response

Keywords: Anti-inflammatories, Cholecalciferol, Inflammation, Vitamin D

Abstract

This study evaluated the effects of daily vitamin D supplementation on the acute inflammatory response in experimental model by different phlogistic agents: carrageenan, prostaglandin and dextran. Animals (rats) orally received (gavage) a single dose of vitamin D or daily supplementation for 7, 15 or 30 days prior to paw edema induced. Vitamin D supplementation for 15 and 30 days significantly reduced the carrageenan-induced inflammatory process, which could be at least partially explained by the reduction of tumor necrosis factor α levels (TNFα). Results indicate that vitamin D supplementation may be a useful therapeutic adjuvant for controlling the acute inflammatory process.

Author Biographies

Jessica Faggion Pinheiro de Oliveira, Universidade Estadual de Maringá - UEM
Master´s in Biosciences and Physiopathology; Chemist at the Hospital Universitário Regional de Maringá (HURM), Brazil.
Andrieli Cansi, Universidade Estadual de Maringá - UEM
Master´s in Biosciences and Physiopathology; Chemist in Chapecó SC Brazil.
Bruno Ambrósio Rocha, Centro Universitário de Adamantina
Doctor´s Degree in Pharmaceutical Sciences; Professor of the Department of Medicine at the Centro Universitário de Adamantina SP Brazil.
Ciomar Aparecida Bersani-Amado, Universidade Estadual de Maringá - UEM
Doctor´s Degree Pharmacology; Professor of the Department of Pharmacology and Therapeutics (UEM) and in the Postgraduate Course in Pharmaceutical Sciences at the Universidade Estadual de Maringá (UEM), Brazil.
Silvana Martins Caparroz-Assef, Universidade Estadual de Maringá - UEM
Doctor´s Degree in Cell Biology; Professor of the Department of Pharmacology and Therapeutics (UEM) and in the Postgraduate Course in Biosciences and Physiopathology at the Universidade Estadual de Maringá (UEM), Brazil.

References

REFERENCES

Jones BJ, Twomey PJ. Issues with vitamin D in routine clinical practice. Rheumatol. 2008; 47: 1267-1268.

Amson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new etiological and therapeutic considerations. Ann Rheum Dis. 2017; 66: 1137-1142.

De Castro LCG. O sistema endocrinológico vitamina D. Arq. Bras. Endocrinol Metab 2011; 55: 566-575.

Lichtenstein A, Ferreira-Júnior M, Sales MM, Aguiar FBD, Fonseca LAM, Sumita NM, et al. Vitamin D: Non-skeletal actions and rational use. Rev. Ass. Med. Bras. 2013; 59: 495-506.

Marques CDL, Dantas AT, Fragoso TS, Duarte ALBP. The importance of vitamin D levels in autoimmune diseases. Rev Bras Reumatol 2010; 50: 67-80.

Zhang Y, Leung DYM, Richers BN, Liu Y, Remigio LK, Riches DW, et al. Vitamin D Inhibits Monocyte/Macrophage Pro-inflammatory Cytokine Production by Targeting Mitogen-Activated Protein Kinase Phosphatase 1. J. Immunol. 2012; 188: 2127–2135.

Inda Filho AJ, Melamed ML. Vitamin D and kidney disease: what we know and what we do not know. J Bras Nefrol. 2013; 35: 323-331.

Wang Q, He Y, Shen Y, Zhang Q, Chen D, Zuo C, et al. Vitamin D Inhinits COX-2 Expression and Inflammatory Response by Targeting Thioesterase Superfamily Member 4. J Biol Chem. 2014; 289: 11681-11694.

Kruit A, Zanen P. The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseases. Ann Clin Biochem. 2016; 49: 534-537.

Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010; 10: 482-496.

Allah ESHA., Ahmed MA, Mola AFA. Comparative study of the effect of verapamil and vitamin D on iron overload-induced oxidative stress and cardiac structural changes in adult male rats. Pathophysiology. 2014; 21: 293-300.

Rocha BA, Gonçalves OH, Leimann FV, Rebecca ES, Silva-Buzanello RA, Araújo PHH, et al. Curcumin encapsulated in poly-L-lactic acid improves its anti-inflammatory efficacy in vivo. Adv. Med. Plant Res. 2014; 2: 62-73.

Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem.

Van Wauwe JP, Gossens JG. Arabinogalactan and dextran-induced ear inflammation in mice: differential inhibition by H1-antihistaminases, 5-HT-serotonin antagonist and lipoxygenase blockers. Agents Actions. 1989; 28: 78-82.

Meotti FC. Processos Redox na Resposta Inflamatória. http://www2.iq.usp.br/docente/flaviam/, 2016 (accessed 21 October 2017).

Moncada SRMJ, Palmer RML, Higgs E. Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 1991; 43: 109-142.

Iwata M, Suzuki S, Asai Y, Inoue T, Takagi K. Involvement of nitric oxide in a rat model of carrageenin-induced pleurisy. Mediators Inflamm. 2010; doi:10.1155/2010/682879.

Moreno J, Krishnan AV, Swami S, Nonn L, Peehl DM, Feldman D. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res. 2005; 65: 7917-7925.

Yip KH, Kolesnikoff N, Yu C, Hauschild N, Taing H, Biggs L, et al. Mechanisms of vitamin D 3 metabolite repression of IgE-dependent mast cell activation. J. Allergy Clin. Immunol. 2014; 133: 1356-1364.

Gürer B, Karakoç A, Bektaşoğlu PK, Kertmen H, Kanat MA, Arıkök AT, et al. Comparative effects of vitamin D and methylprednisolone against ischemia/reperfusion injury of rabbit spinal cords. Eur. J. Pharmacol. 2017; 813: 50-60.

Lisakovska O, Shymanskyy I, Mazanova A, Khomenko A, Veliky M. Vitamin D3 protects against prednisolone-induced liver injury associated with the impairment of the hepatic NF-κB/iNOS/NO pathway. Biochem. Cell Biol. 2016; 95: 213-222.

Wang Q, Li H, Xie H, Fu M, Guo B, Ding Y, Yu H. 25-hydroxyvitamin D3 attenuates experimental periodontitis through downregulation of TLR4 and JAK1/STAT3 signaling in diabetic mice. J. Steroid Biochem. Mol. Biol. 2013; 135: 43-50.

Jiang J, Shi D, Zhou XQ, Yin L, Feng L, Jiang WD, et al. Vitamin D inhibits lipopolysaccharide induced inflammatory response potentially through the Toll like receptor 4 signalling pathway in the intestine and enterocytes of juvenile Jian carp (Cyprinus carpio var. Jian). Br. J. Nut. 2015; 114: 1560-1568.

De Souza WN, Norde MM, Oki E, Rogero MM, Marchioni DM, Fisberg RM, et al. Association between 25-hydroxyvitamin D and inflammatory biomarker levels in a cross-sectional population-based study, São Paulo, Brazil. Nutr. Res. 2016; 36: 1-8.

Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 2012; 60: 870-874.

Chen N, Wan Z, Han SF, Li BY, Zhang ZL, Qin LQ. Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients. 2014; 6: 2206-2216.

Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res. 2011; 31: 607-611.

Farhangi MA, Mesgari-Abbasi M, Hajiluian G. Adipose Tissue Inflammation and Oxidative Stress: the Ameliorative Effects of Vitamin D. Inflammation. 2017; 40: 1688-1697.

Sun X, Zemel MB. 1 alpha, 25 Dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor. Int. J. Obes. 2008; 32: 1305-1311.

M. Blum, G. Dolnikowski, E. Seyoum, S.S. Harris, S.L. Booth, J. Peterson, B. Dawson-Hughes, Vitamin D3 in fat tissue. Endocrine. 2008; 33: 90-94.

Published
2020-06-12
Section
Artigos Originais